Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Osel Devices IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size --
Profile
Price Range 155  to  160 per share
Profile
Min Investment ₹160
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus --
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Osel Devices Limited is a prominent company specializing in advanced medical devices and healthcare solutions. Established with a commitment to innovation, Osel Devices focuses on creating high-quality, reliable products that cater to a range of medical needs. Their portfolio includes cutting-edge diagnostic equipment, therapeutic devices, and patient monitoring systems designed to enhance clinical outcomes and streamline healthcare processes. Osel Devices is renowned for its dedication to research and development, continuously integrating the latest technological advancements to improve patient care and safety. The company's reputation is built on rigorous quality standards and a customer-centric approach, ensuring that their solutions meet the evolving demands of the healthcare industry. With a global presence and a team of skilled professionals, Osel Devices Limited is a key player in advancing medical technology and contributing to the betterment of global health. Read More

Basic Info

Face Value 10 per share

Price 155  to  160 per share

P/E (x) 11.2

Sales( Cr.) 186

PAT( Cr.) 20

EPS 14.3

Draft Prospectus --

Exchange NSE-SME

Promoter

Company Promoters

Rajendra Ravi Shanker Mishra Jyotsna Jawahar

Pre Issue Share Holding 98.5%

Post Issue Share Holding 71.53%

Listing Details:

Listing Price: 198.05

Listing Gain: 19.21%

Current Price: 492.9

Gain On Issue: 492.9 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Sep 16, 2024
Closing Date Sep 19, 2024
Allotment Sep 20, 2024
Refund Sep 23, 2024
Delivery of Shares Sep 23, 2024
Listing Date Sep 24, 2024

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 800 128,000
Retail (Max) 1 800 128,000
S-HNI (Min) 2 1600 256,000
S-HNI (Max) 7 5600 896,000
B-HNI (Min) 8 6400 1,024,000

Objective of the Issue

1. Prepayment or repayment of certain loans availed by the Company. 2. Funding of working capital requirements of the Company. 3. General Corporate Purposes.

Issue

Category Nos Bid Bid (x)
QIB 2208000 172246080 78x
NII 662400 212895360 321.4x
Retail 1545600 318501792 206.1x
EMP 0 0 0x
Total 4416000 857763840 194.2x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Osel Devices Profit & Loss

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 57 65 82 132 186
Other Income 0 0 0 0 0
Total Income 58 66 82 133 187
Total Expenditure 55 61 73 110 153
Operating Profit 3 5 9 23 34
Interest 1 1 1 3 3
Depreciation 1 1 1 1 1
Exceptional Income / Expenses 0 0 0 0 0
Profit Before Tax 2 3 7 19 29
Provision for Tax 1 1 2 6 9
Profit After Tax 1 2 5 13 20
Adjustments 0 0 0 0 0
Profit After Adjustments 1 2 5 13 20
Adjusted Earnings Per Share 1.6 1.8 4 11 12.4

Osel Devices Balance Sheet

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 5 8 12 25 108
Minority's Interest 0 0 0 0 0
Borrowings 3 2 1 8 2
Other Non-Current Liabilities 0 0 0 1 1
Total Current Liabilities 14 24 35 65 87
Total Liabilities 23 33 49 99 198
Fixed Assets 6 5 7 18 17
Other Non-Current Assets 0 0 0 1 1
Total Current Assets 17 28 43 80 180
Total Assets 23 33 49 99 198

Osel Devices Cash Flow

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 3 5 5 1 5
Cash Flow from Operating Activities -3 3 -11 13 -38
Cash Flow from Investing Activities 0 0 -2 -13 -0
Cash Flow from Financing Activities 5 -2 8 4 53
Net Cash Inflow / Outflow 2 1 -4 4 14
Closing Cash & Cash Equivalent 5 5 1 5 19

Osel Devices Ratios

# Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 1.61 1.84 4.04 10.99 12.43
CEPS(Rs) 2.22 2.33 4.54 11.82 13.11
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) 5.93 6.61 10.65 21.96 66.93
Core EBITDA Margin(%) 4.85 6.7 10.55 17.01 17.92
EBIT Margin(%) 4.39 6.32 9.93 16.63 17.4
Pre Tax Margin(%) 3.51 4.58 8.51 14.03 15.53
PAT Margin (%) 2.37 3.25 5.69 9.59 10.75
Cash Profit Margin (%) 3.25 4.11 6.4 10.31 11.34
ROA(%) 6.03 7.63 11.35 17.18 13.53
ROE(%) 27.16 33.6 46.79 67.41 30.09
ROCE(%) 16.95 26.49 35.05 54.36 31.15
Receivable days 44.6 51.25 53.8 54.36 90.21
Inventory Days 25.11 39.79 63.35 60.11 64.76
Payable days 36.61 63.87 82.74 94.45 85.25
PER(x) 0 0 0 0 19.47
Price/Book(x) 0 0 0 0 3.62
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 0.12 0.08 0.23 0.27 2.31
EV/Core EBITDA(x) 2.2 1.11 2.14 1.55 12.86
Net Sales Growth(%) 0 13.58 25.51 61.48 41.01
EBIT Growth(%) 0 63.59 97.22 170.58 47.52
PAT Growth(%) 0 56.1 119.49 172.19 58.09
EPS Growth(%) 0 14.16 119.49 172.19 13.09
Debt/Equity(x) 1.97 1.13 1.45 1 0.46
Current Ratio(x) 1.18 1.17 1.2 1.23 2.05
Quick Ratio(x) 0.9 0.74 0.69 0.84 1.59
Interest Cover(x) 5.02 3.63 7.01 6.38 9.32
Total Debt/Mcap(x) 0 0 0 0 0.13

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 41% 42% 0% 0%
Operating Profit CAGR 48% 89% 0% 0%
PAT CAGR 54% 115% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 83% NA% NA% NA%
ROE Average 30% 48% 41% 41%
ROCE Average 31% 40% 33% 33%

Company Contact Information

Osel Devices Ltd.

Office No.- 712, Naurang House K. G. Marg, Connaught Place Central Delhi

IPO Lead Manager(s)

Osel Devices Ltd.

Horizon Management Pvt Ltd.

Registrar Info

Osel Devices Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!